アジア太平洋の臓器移植診断市場：分析と予測（2023年～2033年）

アジア太平洋地域の臓器移植診断の市場規模は、2023年に12億5,000万米ドルとなりました。

同市場は、2033年には34億5,000万米ドルに達すると予測され、予測期間の2023年～2033年のCAGRは10.73%になるとみられています。臓器不全につながる慢性疾患の増加、移植診断の利用拡大、幹細胞治療の採用拡大、白血病患者の増加による移植診断検査需要の高まり、移植診断領域における分子・ゲノム技術の進歩に起因する利点、償還制度を含む有利な規制環境の存在など、数多くの極めて重要な要因がこの業界の成長を牽引しています。

アジア太平洋の臓器移植診断市場は、様々な要因に後押しされて大きな成長を遂げています。これには、臓器不全につながる慢性疾患の罹患率の上昇、移植診断の利用拡大、同地域における幹細胞治療の受け入れ拡大などが含まれます。さらに、白血病のような疾患の有病率の増加が、移植診断検査の需要を促進しています。この分野はまた、診断能力を高める分子・ゲノム技術の進歩からも恩恵を受けています。さらに、償還制度のような有利な規制条件が市場成長をさらに刺激しています。APACの臓器移植診断市場は、臓器移植における効果的な診断ソリューションに対する需要の高まりに対応し、顕著な拡大を遂げようとしています。

当レポートでは、アジア太平洋の臓器移植診断市場について調査し、市場の概要とともに、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 市場範囲

第2章 調査手法

第3章 臓器移植診断市場：概要

• 現在の市場シナリオ
• 市場フットプリント
• COVID-19による市場への影響

第4章 臓器移植診断市場：業界分析

• 概要
• アジア太平洋における法的要件と枠組み
  • 中国
  • 日本
• 償還シナリオ
• 特許分析

第5章 臓器移植診断市場：市場力学

• 影響分析
• 市場の促進要因
• 市場の抑制要因
• 市場の機会

第6章 地域

• アジア太平洋
  • アジア太平洋の臓器移植検査件数、移植タイプ別
  • 市場規模と予測

第7章 企業プロファイル

List of Figures

• Figure 1: Asia-Pacific Organ Transplant Diagnostics Market, $Billion, 2022-2033
• Figure 2: Organ Transplant Diagnostics Market, Impact Analysis
• Figure 3: Asia-Pacific Organ Transplant Diagnostics Market (by Offering), Share (%), 2022 and 2033
• Figure 4: Asia-Pacific Organ Transplant Diagnostics Market (by Transplant Type), Share (%), 2022 and 2033
• Figure 5: Asia-Pacific Organ Transplant Diagnostics Market (by Application), Share (%), 2022 and 2033
• Figure 6: Asia-Pacific Organ Transplant Diagnostics Market (by Technology), Share (%), 2022 and 2033
• Figure 7: Asia-Pacific Organ Transplant Diagnostics Market (by End User), Share (%), 2022 and 2033
• Figure 8: Organ Transplant Diagnostics Market: Research Methodology
• Figure 9: Primary Research Methodology
• Figure 10: Bottom-Up Approach (Segment-Wise Analysis)
• Figure 11: Top-Down Approach (Segment-Wise Analysis)
• Figure 12: Organ Transplant Diagnostics Market, $Billion, 2022-2033
• Figure 13: Organ Transplant Diagnostics Market, Patent Analysis (by Country), January 2018-December 2022
• Figure 14: Organ Transplant Diagnostics Market, Patent Analysis (by Year), January 2018-December 2022
• Figure 15: Organ Transplant Diagnostics Market, Impact Analysis
• Figure 16: New Liver Cirrhosis and Other Chronic Liver Diseases Cases, Thousand, 2017 and 2021
• Figure 17: Number of Solid Organ Transplants, 2017-2021
• Figure 18: Applications of Stem Cell Therapy
• Figure 19: Number of Transplants Performed and Patients on the Waiting List (by Organ), 2022
• Figure 20: Organ Transplant Diagnostics Market Share and CAGR (by Region), 2022 and 2023-2033
• Figure 21: Asia-Pacific Organ Transplant Diagnostics Market, $Billion, 2022-2033
• Figure 22: Asia-Pacific Organ Transplant Diagnostics Market (by Country), Share (%), 2022 and 2033
• Figure 23: China Organ Transplant Diagnostics Market, $Million, 2022-2033
• Figure 24: India Organ Transplant Diagnostics Market, $Million, 2022-2033
• Figure 25: South Korea Organ Transplant Diagnostics Market, $Million, 2022-2033
• Figure 26: Japan Organ Transplant Diagnostics Market, $Million, 2022-2033
• Figure 27: Australia Organ Transplant Diagnostics Market, $Million, 2022-2033
• Figure 28: Singapore Organ Transplant Diagnostics Market, $Million, 2022-2033
• Figure 29: Rest-of-Asia-Pacific Organ Transplant Diagnostics Market, $Million, 2022-2033
• Figure 30: Total Number of Companies Profiled
• Figure 31: Organ Transplant Diagnostics Market Overview, Key Companies

List of Tables

• Table 1: Key Questions Answered in the Report
• Table 2: Key Coverage Providers for Organ Transplant Diagnostics Tests
• Table 3: Asia-Pacific Organ Transplant Diagnostics Market, Impact Analysis
• Table 4: Asia-Pacific Organ Transplant Test Volume, by Transplant Type, 2021

The Asia-Pacific Organ Transplant Diagnostics Market Expected to Reach $3.45 Billion by 2033

Introduction to Asia-Pacific Organ Transplant Diagnostics Market

In 2023, the Asia-Pacific organ transplant diagnostics market was valued at $1.25 billion and is expected to reach $3.45 billion by 2033, with a CAGR of 10.73% during the forecast period 2023-2033. Numerous pivotal factors are driving growth in this industry, comprising a rise in chronic diseases leading to organ failure, increased utilization of transplant diagnostics, growing adoption of stem cell therapy, heightened demand for transplant diagnostic tests due to an uptick in leukemia cases, advantages stemming from advancements in molecular and genomic technologies in the transplant diagnostics realm, and the presence of favorable regulatory environments, including reimbursement schemes.

Market Introduction

The Asia-Pacific (APAC) organ transplant diagnostics market is experiencing significant growth, propelled by various factors. This includes the escalating incidence of chronic diseases leading to organ failure, the expanding utilization of transplant diagnostics, and a rising acceptance of stem cell therapy in the region. Additionally, the increasing prevalence of conditions like leukemia is driving demand for transplant diagnostic tests. The sector also benefits from advancements in molecular and genomic technologies, enhancing diagnostic capabilities. Furthermore, favorable regulatory conditions, such as reimbursement schemes, further stimulate market growth. With these dynamics at play, the APAC organ transplant diagnostics market is poised for notable expansion, catering to the growing demand for effective diagnostic solutions in organ transplantation procedures across the region.

Market Segmentation:

Segmentation 1: by Country

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Growth/Marketing Strategy: The APAC organ transplant diagnostics market has witnessed major development by key players operating in the market, such as product launches, business expansions, partnerships, collaborations, mergers and acquisitions, funding activities, and regulatory and legal approvals. The favored strategy for the companies has been synergistic activities such as partnerships, collaborations, expansions, and funding activities.

Competitive Strategy: The key players in the APAC organ transplant diagnostics market analyzed and profiled in the study involve established and emerging players that offer different products and services for organ transplant diagnostics. Moreover, a detailed competitive benchmarking of the players operating in the APAC organ transplant diagnostics market has been done to help the reader understand the ways in which players stack against each other, presenting a clear market landscape. Moreover, comprehensive competitive strategies such as partnerships, agreements, collaborations, and mergers and acquisitions will help the reader understand the untapped revenue pockets in the market.

Table of Contents

Executive Summary

1 Market Scope

• 1.1 Key Questions Answered in the Report:

2 Research Methodology

• 2.1 Organ Transplant Diagnostics Market: Research Methodology
• 2.2 Data Sources
  • 2.2.1 Primary Data Sources
  • 2.2.2 Secondary Data Sources
• 2.3 Market Estimation Model
• 2.4 Criteria for Company Profiling

3 Organ Transplant Diagnostics Market: Overview

• 3.1 Current Market Scenario
  • 3.1.1 For Researchers
  • 3.1.2 For Diagnostics
• 3.2 Market Footprint
• 3.3 COVID-19 Impact on Market
  • 3.3.1 Impact on Operations
  • 3.3.2 COVID-19 Impact: Current Scenario of Market
  • 3.3.3 Pre- and Post-COVID-19 Impact Assessment
    • 3.3.3.1 Pre-COVID-19 Phase
    • 3.3.3.2 Post-COVID-19 Phase

4 Organ Transplant Diagnostics Market: Industry Analysis

• 4.1 Overview
• 4.2 Legal Requirements and Framework in Asia-Pacific
  • 4.2.1 China
  • 4.2.2 Japan
• 4.3 Reimbursement Scenario
• 4.4 Patent Analysis
  • 4.4.1 Patent Filing Trend (by Country)
  • 4.4.2 Patent Filing Trend (by Year)

5 Organ Transplant Diagnostics Market: Market Dynamics

• 5.1 Impact Analysis
• 5.2 Market Drivers
  • 5.2.1 Rise in Incidence of Chronic Diseases Leading to Organ Failure Increases the Use of Transplant Diagnostics
  • 5.2.2 Increase in Adoption of Stem Cell Therapy and Incidences of Leukemia Leading to an Upsurge in Demand for Transplant Diagnostics Tests
  • 5.2.3 Presence of Favorable Regulatory Scenarios including Reimbursement Schemes for Some Organ Transplant Diagnostics
  • 5.2.4 Advantages of Developing Advanced Molecular and Genomic Technologies in Transplant Diagnostics Tests
• 5.3 Market Restraints
  • 5.3.1 Increased Gap in Organ Donation and Organ Transplant Demand Hinders the Growth of Organ Transplant Diagnostics Market
  • 5.3.2 High Cost of Investment for Transplant Diagnostics Tests Acts as a Barrier to Growth of the Market
• 5.4 Market Opportunities
  • 5.4.1 Development of Non-Invasive Techniques for Monitoring Transplant Recipients using NGS
  • 5.4.2 Advancements in Human Leukocyte Antigen (HLA) Typing Tests for Organ Transplant

6 Region

• 6.1 Asia-Pacific
  • 6.1.1 Asia-Pacific Organ Transplant Test Volume, by Transplant Type
  • 6.1.2 Market Sizing and Forecast
    • 6.1.2.1 Asia-Pacific Organ Transplant Diagnostics Market (by Country)
      • 6.1.2.1.1 China
      • 6.1.2.1.2 India
      • 6.1.2.1.3 South Korea
      • 6.1.2.1.4 Japan
      • 6.1.2.1.5 Australia
      • 6.1.2.1.6 Singapore
      • 6.1.2.1.7 Rest-of-Asia-Pacific

7 Company Profiles

• 7.1 Overview
• 7.2 Manufacturers